Product profile · United States
Lucentis
· Patent Litigation & Settlement History ↓
Current GenericRadar decision
GNR judgment: DISCONTINUED. Reference year: 2023. Anchor type: PRODUCT_STATUS. Patent anchor: not recorded. Exclusivity anchor: not recorded. Anchor date: 2023-08-17. Patent tail: not established. Exclusivity tail: not established. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.
Patent estate
| Patent | Effective date | Official listing | TRUE_DS | DS grade | Claim classification / basis | PTE | PED | Family |
|---|---|---|---|---|---|---|---|---|
| 6716602 | 2021-11-01 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 6828121 | 2022-07-08 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 9688775 | 2022-12-31 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 6921659 | 2023-10-17 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 8383773 | 2023-12-13 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 8574869 | 2028-07-08 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 10421984 | 2033-09-19 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 9765379 | 2034-03-10 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 10017732 | 2034-03-14 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 10829732 | 2034-03-14 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
| 10112994 | 2035-11-05 | PURPLE_BOOK — | — | — | — Original PB source record retained in gnr_patent_source_records. No TRUE_DS/DS-equivalent judgment. | — | — | — |
Regulatory exclusivity
| Code | Start date | End date | Scope | Entire product | All indications | Full coverage date | Combination | Source |
|---|---|---|---|---|---|---|---|---|
| No exclusivity facts are recorded in this product snapshot. | ||||||||
2026-10-10 · PENDING_EXCLUSIVITY_CONFIRMATION · Historical coverage: NOT_COMPLETE
Generic approval evidence
| Application / product | Event | Final date | Tentative date | Applicant | Authorized generic | Exact mapping | Source |
|---|---|---|---|---|---|---|---|
| 761202 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2021-09-17 | — | Samsung Bioepis Co., Ltd. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761165 / 001 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Sandoz Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761165 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-08-02 | — | Sandoz Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761165 / 002 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Sandoz Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761165 / 002 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-08-02 | — | Sandoz Inc. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761202 / 001 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Samsung Bioepis Co., Ltd. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761473 / 001 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Zydus Lifesciences Global FZE | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761473 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2025-12-18 | — | Zydus Lifesciences Global FZE | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761473 / 002 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2025-12-18 | — | Zydus Lifesciences Global FZE | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761473 / 002 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Zydus Lifesciences Global FZE | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 001 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 001 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 002 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 002 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 003 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 003 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 004 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761480 / 004 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Lupin Limited (Biotech Division) | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761202 / 002 | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-09-04 | — | Samsung Bioepis Co., Ltd. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 761202 / 002 | INTERCHANGEABILITY · INTERCHANGEABLE | — | — | Samsung Bioepis Co., Ltd. | N | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
Market Entry Information
API filings, authorized generics and linked regulatory milestones.
API Master Files & Certifications 0 records
Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.
| API | Holder / manufacturer | Holder country | Filing type | Number | Status | Filed date | Available for reference | Source | Last verified |
|---|---|---|---|---|---|---|---|---|---|
| No master-file or certification records are linked through public manufacturer portfolios. | |||||||||
Authorized Generics 0 records
Authorized generics are shown separately from independent ANDA approvals.
| Application / product | Applicant | Event / status | First marketed | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No authorized-generic records are linked to this product. | ||||||
Tentative ANDA Approvals 0 records
Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.
| Application / product | Applicant | Event / status | Tentative date | Follow-up final approval | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|---|
| No tentative-approval records are linked to this product. | |||||||
Paragraph IV Challenges 0 records
Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.
| Application / product | Applicant | Event / status | Certification event date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No structured Paragraph IV certification events are linked in the available approval evidence. | ||||||
Final ANDA Approvals 10 records
Approval dates do not establish commercial launch. Product mapping is shown for each linked record.
| Application / product | Applicant | Event / status | Final approval date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| 761202 / 001 | Samsung Bioepis Co., Ltd. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2021-09-17 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761165 / 001 | Sandoz Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-08-02 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761165 / 002 | Sandoz Inc. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2022-08-02 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761473 / 001 | Zydus Lifesciences Global FZE | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2025-12-18 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761473 / 002 | Zydus Lifesciences Global FZE | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2025-12-18 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761480 / 001 | Lupin Limited (Biotech Division) | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761480 / 002 | Lupin Limited (Biotech Division) | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761480 / 003 | Lupin Limited (Biotech Division) | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761480 / 004 | Lupin Limited (Biotech Division) | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-06-02 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 761202 / 002 | Samsung Bioepis Co., Ltd. | BIOSIMILAR_APPROVAL · BIOSIMILAR_APPROVED | 2026-09-04 | REFERENCE_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
Independent legal-event information
Litigation & Settlement History
Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.
No litigation or settlement record currently linked to this product.